FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221124012> ?p ?o ?g. }

• W4221124012 abstract "Background: It is sometimes difficult to distinguish between asthma and bronchiectasis as their symptoms overlap, and these two diseases are associated with pulmonary tuberculosis (PTB) or pneumonia. Objective: The purpose of this study is to determine the effects of bronchodilator drugs, steroids, antidepressants drugs, and antianxiety drugs on the risks of PTB or pneumonia in patients with bronchiectasis-asthma combination or bronchiectasis-asthma-chronic obstructive pulmonary disease combination-BCAS cohort. Methods: After propensity score matching, we retrospectively studied patients with BCAS (N = 620) and without BCAS (N = 2,314) through an analysis. The cumulative incidence of PTB or pneumonia was analyzed through Cox proportional regression. After adjustment for sex, age, comorbidities, and medications [including long-acting beta2 agonist/muscarinic antagonists (LABAs/LAMAs), short-acting beta2 agonist/muscarinic antagonists (SABAs/SAMAs), leukotriene receptor antagonist, montelukast, steroids (inhaled corticosteroids, ICSs; oral steroids, OSs), anti-depressants (fluoxetine), and anti-anxiety drugs (benzodiazepines, BZDs)], we calculated the adjusted hazard ratios (aHR) and their 95% confidence intervals (95% CI) for these risks. Similar to OSs, ICSs are associated with an increased risk of PTB or pneumonia, lumping these two as steroids (ICSs/OSs). Results: For the aHR (95% CI), with non-LABAs/non-OSs as the reference 1, the use of LABAs [0.70 (0.52-0.94)]/OSs [0.35 (0.29-0.44)] was associated with a lower risk of PTB or pneumonia. However, the current use of LABAs [2.39 (1.31-4.34)]/SABAs [1.61 (1.31-1.96)], steroids [ICSs 3.23 (1.96-5.29)]/OSs 1.76 (1.45-2.14)], and BZDs [alprazolam 1.73 (1.08-2.75)/fludiazepam 7.48 (1.93-28.9)] was associated with these risks. The current use of LAMAs [0.52 (0.14-1.84)]/SAMAs [1.45 (0.99-2.11)] was not associated with these risks. Conclusion: The current use of LAMAs/SAMAs is relatively safe with respect to PTB or pneumonia risks, but LABAs/SABAs, steroids, and BZDs could be used after evaluation of the benefit for the BCAS cohort. However, we must take the possible protopathic bias into account." @default.
• W4221124012 created "2022-04-03" @default.
• W4221124012 creator A5005660358 @default.
• W4221124012 creator A5047902750 @default.
• W4221124012 creator A5055936884 @default.
• W4221124012 creator A5072709640 @default.
• W4221124012 creator A5091403499 @default.
• W4221124012 date "2022-03-30" @default.
• W4221124012 modified "2023-10-17" @default.
• W4221124012 title "Asthma Therapies on Pulmonary Tuberculosis Pneumonia in Predominant Bronchiectasis–Asthma Combination" @default.
• W4221124012 cites W1970642005 @default.
• W4221124012 cites W2025462328 @default.
• W4221124012 cites W2032708935 @default.
• W4221124012 cites W2055648403 @default.
• W4221124012 cites W2059644513 @default.
• W4221124012 cites W2071660622 @default.
• W4221124012 cites W2092940168 @default.
• W4221124012 cites W2119837675 @default.
• W4221124012 cites W2145285461 @default.
• W4221124012 cites W2166855319 @default.
• W4221124012 cites W2293877492 @default.
• W4221124012 cites W2322959427 @default.
• W4221124012 cites W2472502994 @default.
• W4221124012 cites W2484722187 @default.
• W4221124012 cites W2511614083 @default.
• W4221124012 cites W2514724873 @default.
• W4221124012 cites W2556938597 @default.
• W4221124012 cites W2750425693 @default.
• W4221124012 cites W2765758708 @default.
• W4221124012 cites W2767664315 @default.
• W4221124012 cites W2778460624 @default.
• W4221124012 cites W2784530287 @default.
• W4221124012 cites W2787234021 @default.
• W4221124012 cites W2789180591 @default.
• W4221124012 cites W2802300814 @default.
• W4221124012 cites W2884457464 @default.
• W4221124012 cites W2886711327 @default.
• W4221124012 cites W2897731470 @default.
• W4221124012 cites W2898446704 @default.
• W4221124012 cites W2906055192 @default.
• W4221124012 cites W2914854400 @default.
• W4221124012 cites W2921678383 @default.
• W4221124012 cites W2943005888 @default.
• W4221124012 cites W2979964153 @default.
• W4221124012 cites W3006317414 @default.
• W4221124012 cites W3007634464 @default.
• W4221124012 cites W3008844618 @default.
• W4221124012 cites W3008887637 @default.
• W4221124012 cites W3011439370 @default.
• W4221124012 cites W3011807353 @default.
• W4221124012 cites W3034664541 @default.
• W4221124012 cites W3095522037 @default.
• W4221124012 cites W3134883344 @default.
• W4221124012 cites W3186030568 @default.
• W4221124012 cites W3197307495 @default.
• W4221124012 cites W3201176799 @default.
• W4221124012 doi "https://doi.org/10.3389/fphar.2022.790031" @default.
• W4221124012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35431916" @default.
• W4221124012 hasPublicationYear "2022" @default.
• W4221124012 type Work @default.
• W4221124012 citedByCount "1" @default.
• W4221124012 countsByYear W42211240122023 @default.
• W4221124012 crossrefType "journal-article" @default.
• W4221124012 hasAuthorship W4221124012A5005660358 @default.
• W4221124012 hasAuthorship W4221124012A5047902750 @default.
• W4221124012 hasAuthorship W4221124012A5055936884 @default.
• W4221124012 hasAuthorship W4221124012A5072709640 @default.
• W4221124012 hasAuthorship W4221124012A5091403499 @default.
• W4221124012 hasBestOaLocation W42211240121 @default.
• W4221124012 hasConcept C126322002 @default.
• W4221124012 hasConcept C207103383 @default.
• W4221124012 hasConcept C2776042228 @default.
• W4221124012 hasConcept C2776322731 @default.
• W4221124012 hasConcept C2777714996 @default.
• W4221124012 hasConcept C2777914695 @default.
• W4221124012 hasConcept C2779379686 @default.
• W4221124012 hasConcept C44249647 @default.
• W4221124012 hasConcept C71924100 @default.
• W4221124012 hasConceptScore W4221124012C126322002 @default.
• W4221124012 hasConceptScore W4221124012C207103383 @default.
• W4221124012 hasConceptScore W4221124012C2776042228 @default.
• W4221124012 hasConceptScore W4221124012C2776322731 @default.
• W4221124012 hasConceptScore W4221124012C2777714996 @default.
• W4221124012 hasConceptScore W4221124012C2777914695 @default.
• W4221124012 hasConceptScore W4221124012C2779379686 @default.
• W4221124012 hasConceptScore W4221124012C44249647 @default.
• W4221124012 hasConceptScore W4221124012C71924100 @default.
• W4221124012 hasLocation W42211240121 @default.
• W4221124012 hasLocation W42211240122 @default.
• W4221124012 hasLocation W42211240123 @default.
• W4221124012 hasOpenAccess W4221124012 @default.
• W4221124012 hasPrimaryLocation W42211240121 @default.
• W4221124012 hasRelatedWork W1957770986 @default.
• W4221124012 hasRelatedWork W2011612780 @default.
• W4221124012 hasRelatedWork W2043240135 @default.
• W4221124012 hasRelatedWork W2155991787 @default.
• W4221124012 hasRelatedWork W2462739481 @default.
• W4221124012 hasRelatedWork W2469072756 @default.
• W4221124012 hasRelatedWork W2619141725 @default.
• W4221124012 hasRelatedWork W2894848803 @default.

• next